Office of Fair Trading
05 March 2003

'INVITATION TO COMMENT'

Proposed acquisition by Celltech Group plc of Oxford Glycosciences plc.

The Director General of Fair Trading is considering whether the above
acquisition qualifies for investigation under the merger provisions of the
FairTrading Act 1973. Should it be found to qualify, the Director General
willconsider it further with a view to advising the Secretary of State for
Trade andIndustry under section 76(1) of the Act as to whether or not the
merger shouldbe referred to the Competition Commission for investigation
and report.
Affected Sector: Pharmaceuticals/Biotechnology.

Please send written representations about any competition or public
interest implications to:

Ms F Elly

Office of Fair Trading

Fleetbank House

2-6 Salisbury Square

London EC4Y 8JX

FAX: 020-7211-8916

to arrive by 19 March 2003.